Research, Charts & Company Announcements
Research Tree offers INPHI CORP research coverage from 0 professional analysts, and we have 0 reports on our platform.
Our simple but effective charting function allows for a quick scan of INPHI CORP's performance over multiple time horizons.
Frequency of research reports
Research reports on INPHI CORP
Providers covering INPHI CORP
Research on related companies
View the latest research on other companies in the sector, published by expert analysts across the city, at some of the best quality Banks, Brokers, and Independent Providers in the market.
17 Oct 16
Avacta* (AVCT): Act now (CORP) | Tristel* (TSTL): A strong FY 2016 (CORP) | Bioventix* (BVXP): FY 2016 results (CORP) | Elecosoft* (ELCO): SaaS model strengthened through acquisition (CORP) | Lok’nStore* (LOK): NAV up 28% (CORP) | Omega Diagnostics* (ODX): Mid year trading update (CORP) | Mortice* (MORT): Positive trading update (CORP)
Strong prelims demonstrate strategic execution
18 Oct 16
Prelims delivered EBITDA of £8.0m (comfortably ahead of £7.6mE) from revenue of £26.9m (£27.5mE), with cash very strong at £17.3m (£15.3mE), as detailed at the July trading update. Consistently strong revenue growth included 21% in the established UK market (20% of 2H16 revenue) and 58% across the rest of the world (including 43% constant currency growth in the US). Geographical expansion, product innovation and strategic partnerships continue to be well executed, supported by a strong balance sheet that is also able to accommodate a growing dividend, and an FY16 special dividend given strong cash generation. With EBITDA and cash performance ahead of expectations and board confidence displayed in the dividend, forecasts remain primed for upgrade: target price 70p (55p).
N+1 Singer - NCC Group - Strong revenue but margins weaker in H1
20 Oct 16
NCC’s trading update for the four months to September shows continued strong revenue growth, but margin pressures in the first half mean that profit for the year will be more second half weighted than usual. Group revenue increased 36% in the period (+21% organic) with Assurance and Escrow both growing well (+25% and +4% respectively). The Assurance division has seen three unrelated large contract cancellations however, as well as some difficulties with some managed services renewals. We are not making any changes to our forecasts at this stage but now expect a significant second half weighting to profits. We remain supportive of the story but with the shares priced for perfection, we downgrade to Hold, with a target price of 353p (from 384p).
N+1 Singer - IQE - Site visit confirms large growth opportunity
19 Oct 16
We visited IQE in Cardiff yesterday. The visit focused on the fast growing Photonics division as well as potential applications for the recently acquired cREO technology. We have come away further convinced of the large and diverse, near term opportunity for IP rich Photonics wafers, and believe IQE is uniquely placed to service this market. The group is also exposed to multiple potentially game-changing medium term opportunities, which the cREO technology will help address. We expect the higher value Photonics division to continue its rapid growth (+45% growth y-o-y reported in H1’16), underpinning our positive stance and Buy recommendation.
N+1 Singer - Morning Song 18-10-2016
18 Oct 16
1Spatial delivered a soft first half performance showing slower revenue development in its higher-margin Geospatial business, thereby impacting overall adjusted EBITDA. The group has a strong order book (of which the Geospatial component is up 30% y-o-y) and has built up a solid pipeline of opportunities which it expects to convert in the next six months. As such, the group is maintaining guidance for the year, albeit performance will be heavily H2-weighted. We believe the 1.1x EV/Sales and 6.2x EV/EBITDA Jan’17 rating does not reflect the potential of an IP-rich, productised business that is leveraging partnerships to scale growth – but recognise that stronger revenue traction is required to buoy confidence and drive the re-rating of the shares.
N+1 Singer - Dotdigital Group - 26% organic growth, special divi and +ve outlook
18 Oct 16
dotDigital delivered another year of strong growth, profitability and cash generation. All key financial metrics grew in double-digit terms (all organic) driven by growth in customers, growth in average spend and an increasing contribution from international. The Board is proposing a 19% increase in the ordinary dividend and a 0.41p special dividend. Our profit forecasts in 2017 and 2018 are unchanged, with EBITDA growth of 26% and 22%. dotDigital’s prospects remain healthy with new avenues of growth being developed through wider partnerships and broadening international reach. With the vast majority of revenues relating to monthly subscription revenues and a diverse customer base (biggest client accounts for c.1.5% of sales), the stock offers one of the most secure strong organic growth stories in the market.